https://doi.org/10.55788/36900cf3
“Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is the current standard for the diagnosis of pancreatic solid lesions,” stated Dr Serena Stigliano (University of Rome, Italy) [1]. “However, endoscopic ultrasound sampling is associated with a risk of non-diagnostic or inconclusive results, with a negative predictive value around 70–80%.”
The multicentre study investigated the accuracy of FCM in diagnosing EUS-TA samples from pancreatic solid lesions and its agreement with the final histological diagnosis. “FCM is an optical imaging technique that provides digital microscopical images of fresh tissue in real-time,” clarified Dr Stigliano. The study included 80 participants with focal pancreatic solid lesions. After obtaining the samples, they were evaluated by FCM (VivaScope) and categorised as inadequate or adequate. The adequate samples were further classified as benign, suspicious, or malignant before undergoing standard histological evaluation.
A 22-gauge needle was used in 66.3% of the participants, while a 25-gauge needle was used in 32.5%. Dr Stigliano reported that 96.3% of the samples were categorised as adequate. The sensitivity of VivaScope was 97.3%, the specificity was 80%, and the overall accuracy was 96.3%. Overall, the concordance between the VivaScope diagnosis and the final histological diagnosis was moderate (Cohen's kappa coefficient 0.58). Needle type, size, and EUS technique were not associated with obtaining diagnostic samples.
Thus, FCM can quickly deliver information about sample adequacy and provide accurate diagnoses of EUS-TA with high accuracy. “It offers the opportunity of creating a digital image and a distant diagnosis, supporting remote consultations,” Dr Stigliano concluded.
- Stigliano S, et al. Digital confocal microscopy for real-time diagnosis of pancreatic solid lesion: a multicentre study. LB17, UEG Week 2024, 12–15 October, Vienna, Austria.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« An accelerated treatment approach may save lives in pancreatic walled-off necrosis Next Article
Upadacitinib associated with normalisation of HRQoL in UC »
« An accelerated treatment approach may save lives in pancreatic walled-off necrosis Next Article
Upadacitinib associated with normalisation of HRQoL in UC »
Table of Contents: UEGW 2024
Featured articles
Cendakimab meets primary endpoints in eosinophilic oesophagitis
Liver: Exploring New Therapeutics
Encouraging results for L-carnitine in metabolic dysfunction-associated steatotic liver disease
Other Late-breaking Studies from UEGW
TACITO: Does faecal microbiota transplantation improve survival in mRCC?
Is faecal microbiota transplantation a viable option to treat primary C. difficile infections?
Cendakimab meets primary endpoints in eosinophilic oesophagitis
IBD: New Drugs, Established Agents, and Prevention
LOVE-CD: Vedolizumab yields better outcomes in early than in late CD
Moving towards the prevention of IBD
New insights into perianal fistulising CD pathogenesis may lead to new therapies
Risankizumab influences key pathogenic Th17 cells in CD
Meaningful corticosteroid-sparing effect of mirikizumab in UC
Extending ustekinumab dosing interval does not influence drug survival in IBD
CULTIVATE: Promising signal for etrasimod in Crohn’s disease
Tamuzimod delivers promising long-term data in UC
TL1A inhibitor tulisokibart shows potential in UC
Upadacitinib associated with normalisation of HRQoL in UC
Pancreas: Improved Diagnostics and Treatment Algorithms
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA
An accelerated treatment approach may save lives in pancreatic walled-off necrosis
Irritable Bowel Syndrome: from Guar Gum to Tradipitant
Guar gum alleviates IBS-related constipation in a randomised controlled trial
How useful is colonoscopy for constipation in young women?
Related Articles
October 23, 2019
Human milk oligosaccharides improve IBS symptoms
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com